Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes
Also in Life Sciences
Science
Biotech Hangout
by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Today: #112 in Science on our combined chart.
Today: #124 in Science, United Kingdom on our combined chart.
Today: #142 in Science, Canada on our combined chart.
Chart positions today · United States
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Biotech Hangout, try…
Cancer Connections
Also in Life Sciences
EHA Unplugged
Also in Life Sciences
Let's Talk Micro
Also in Life Sciences
Les voies métaboliques
Also in Life Sciences
The Chain: Protein Engineering Podcast
Also in Life Sciences
Ranking history · United States
Latest daily rankings: Oct 27. New rankings will appear after the next update.
Position on the Science combined chart over the last 14 days. Toggle platforms to compare their positions. Lower rank numbers are better.
Episode releases
View as table
| Date | Combined Rank | Apple Podcasts | Pocket Casts | Castbox |
|---|---|---|---|---|
| Oct 27 | #112 | #90 | — | #93 |
| Oct 26 | #120 | #106 | — | #93 |
| Oct 25 | #111 | #88 | — | — |
| Oct 24 | #106 | #90 | — | #92 |
| Oct 23 | #104 | #89 | — | #59 |
| Oct 22 | #73 | #48 | — | #48 |
| Oct 21 | #75 | #51 | #49 | #51 |
| Oct 20 | #64 | #39 | #40 | #41 |
| Oct 19 | #76 | #47 | — | #50 |
| Oct 18 | #88 | #57 | — | — |
| Oct 16 | #183 | #167 | — | — |
| Oct 15 | #168 | #152 | — | — |
| Oct 14 | — | #195 | — | — |
Latest episodes
-
Episode 200 - October 23, 2026
October 23, 2026 · 1 hr 4 minOn this week's 200th episode, Daphne Zohar, Brad Loncar, Chris Garabedian, Sam Fazeli, Eric Schmidt, Josh Schimmer, Matt Gline, and special guest former Silence CEO Ali Mortazavi kicked off by reflecting on five years of Biotech Hangout…
-
Episode 199 - October 16, 2026
October 16, 2026 · 59 minOn this week’s episode, Graig Suvannavejh, Paul Matteis, Brian Skorney, Yaron Werber, and Jake Becraft opened with a look at the biotech market, with the XBI down roughly 700 basis points in two weeks but still up about 20% year to date…
-
Episode 198 - October 2, 2026
October 2, 2026 · 1 hr 0 minOn this week's episode, Graig Suvannavejh, Sam Fazeli, Eric Schmidt, and Brian Skorney open with a look at the public markets, noting the XBI is up 27% year-to-date but down about 9% since its August high. The co-hosts then touched on…
-
Episode 197 - September 25, 2026
September 25, 2026 · 59 minOn this week's episode, Sam Fazeli, Yaron Werber, Brian Skorney, and Matt Gline open with the IPO market, noting record average raise sizes even as XBI softens. The group turns to policy, unpacking newly FOIA-disclosed details of Pfizer's…
-
Episode 196 - September 18, 2026
September 25, 2026 · 55 minOn this week's episode, Josh Schimmer, Eric Schmidt, Paul Matteis, and guest Adam Feuerstein open with the OpenAI/Hugging Face AI agent controversy, debating whether calls for AI regulation reflect genuine safety concern or capital…
Show 7 more episodesShow fewer episodes
-
Episode 195 - September 11, 2026
September 15, 2026 · 1 hr 0 minOn this week's episode, Tess Cameron, Brian Skorney, Paul Matteis, and Yaron Werber open with a look at markets, noting the XBI slipped just over 3% amid concerns about energy prices, inflation, and long-term U.S. fiscal health weighing on…
-
Episode 194 - August 28, 2026
August 28, 2026 · 1 hr 2 minOn this week's episode, Daphne Zohar, Eric Schmidt, Sam Fazeli, and Graig Suvannavejh open with a strong week for biotech, partially driven by M&A, noting it's already past 2025's full-year total. The group turns to Moderna, whose melanoma…
-
Episode 193 - August 14, 2026
August 14, 2026 · 59 minOn this week's episode, Chris Garabedian, Graig Suvannavejh, Paul Matteis, and Tess Cameron open with the biotech market. They describe 2026 as strong but discerning, with 19 Nasdaq IPOs this year and generalist investors still not fully…
-
Episode 192 - August 7, 2026
August 7, 2026 · 1 hr 4 minOn this week’s episode, Sam Fazeli, Brian Skorney, Yaron Werber, and Strand Therapeutics CEO Jake Becraft open with the wave of dealmaking and a solid Q2 earnings season, then turn to the reports of the potential AstraZeneca/Bristol Myers…
-
Episode 191 - July 31, 2026
August 3, 2026 · 1 hr 0 minOn this week's episode, Graig Suvannavejh, Tim Opler, Yaron Werber, Paul Matteis, and Brian Skorney kicked off with a review of the market, noting pressure in the XBI despite a longer-term bounce-back from trough levels, though they see…
-
Episode 190 - July 24, 2026
July 24, 2026 · 59 minOn this week's episode, Josh Schimmer, Brian Skorney, Eric Schmidt, and Brad Loncar kick off with IPOs and raises, including Scribe's IPO, the first preclinical biotech IPO since the COVID era, which priced in a modest but upsized deal…
-
Episode 189 - July 17, 2026
July 17, 2026 · 58 minOn today’s episode, Yaron Werber, John Maraganore, Sam Fazeli, and Matt Gline open with a discussion of biotech market volatility, with Matt noting that it often seems driven more by opaque factor dynamics than company-specific…
About the show
A weekly discussion of all things biotech – breaking news, data, deals, and FDA actions – with a community of biotech industry leaders and experts. Join the live streams hosted by @BiotechCH, @daphnezohar, @bradloncar and @biotech1 on Twitter Spaces every Friday at 12pm ET.